Aukera Therapeutics Company
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein-related diseases such as cancer and neurogenerative diseases. Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel.
Founded Date:
2021-01-01
Employee Number:
1-10
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
BaseLaunch, Kickfund, Venture Kick, Z?rcher Kantonal Bank
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Driton Liko, Stefan Imseng